BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V. Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature. Stem Cells Cloning 2018;11:95-113. [PMID: 30568468 DOI: 10.2147/SCCAA.S135414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Guz W, Ożóg Ł, Aebisher D, Filip R. The use of magnetic resonance imaging technique and 3D printing in order to develop a three-dimensional fistula model for patients with Crohn's disease: personalised medicine. Prz Gastroenterol 2021;16:83-8. [PMID: 33986892 DOI: 10.5114/pg.2020.101629] [Reference Citation Analysis]
2 Altemus J, Dadgar N, Li Y, Lightner AL. Adipose tissue-derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease. J Cell Physiol 2022. [PMID: 35522572 DOI: 10.1002/jcp.30756] [Reference Citation Analysis]
3 Li Y, Altemus J, Lightner AL. Mesenchymal stem cells and acellular products attenuate murine induced colitis. Stem Cell Res Ther 2020;11:515. [PMID: 33256827 DOI: 10.1186/s13287-020-02025-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Cho YJ, Kwon H, Kwon YJ, Kim KM, Oh SH, Kim DY. Efficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn's complex fistula: a Phase IV clinical study. Ann Surg Treat Res 2021;101:58-64. [PMID: 34235117 DOI: 10.4174/astr.2021.101.1.58] [Reference Citation Analysis]